FEATURES OF BIOIMPEDANSOMETRY IN PATIENTS WITH CHRONIC PANCREATITIS AND ATHEROSCLEROSIS
DOI:
https://doi.org/10.11603/1811-2471.2019.v0.i1.10061Keywords:
chronic pancreatitis, atherosclerosis, bioimpedance examinationAbstract
The results of bioimpedansometry in patients with chronic pancreatitis and atherosclerosis were studied.
The aim – research the features of bioimpedansometry in patients with chronic pancreatitis (CP) and atherosclerosis.
Material and Methods. The study included 60 patients with CP in age from 40 to 60 years. The control group consisted of 20 healthy individuals aged from 40 to 60 years. Depending on the presence of violations in the lipid profile, all patients were divided into two groups. The group 1 included 28 patients with CP without atherosclerotic changes, the group 2 – 32 patients with CP and atherosclerosis. All patients were tested for blood lipid spectrum with the determination of total blood plasma cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), atherogenic coefficient (CA). In addition, all patients underwent bioimpedance studies of body composition with the determination of the level of fat, muscle, bone mass, body fluids and calculation of body mass index (BMI). To interpret the results of the study, all patients were subdivided according to gender.
Results. The results suggest that in patients with CP and atherosclerosis, even with a normal indicator of BMI, obesity is observed according to the results of bioimpedance studies of body composition, which is accompanied by a more severe course of the disease and an unfavorable prognosis. Therefore, the complex of measures for the diagnosis of CP should include not only the definition of lipid metabolism and BMI, but also the study of body composition.
Conclusions. All patients were tested for blood lipid spectrum with the determination of total blood plasma cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL) and low-density lipoprotein (LDL) cholesterol (AT). Also, all patients underwent bioimpedance study of body composition with the determination of the level of fat, muscle, bone mass, body fluids and calculation of body mass index (BMI).
The study revealed a lack of body mass according to the results of bioimpedance examination and BMI in patients with chronic pancreatitis without atherosclerotic changes. In patients with chronic pancreatitis and atherosclerosis, “latent” obesity was established according to the results of bio-impedancemetry with a normal value of BMI.
References
Harkusha, S.L., & Korzun, V.N. (2015). Dosvid roboty kabinetu korektsii lipidnoho spektra krovi ta likuvannia riznykh form ozhyrinnia u profilaktytsi vynyknennia zakhvoriuvan systemy krovoobihu [The experience of the office of correction of the lipid spectrum of blood and treatment of various forms of obesity in preventing the onset of circulatory system diseases]. Dovkillia ta zdorovia – Environment and Health, 1 (72), 31-34 [in Ukrainan].
Gubergrits, N.B., & Golubova, O.A. (2014). Bioimpedansometriya u bolnykh s khronicheskym pankreatitom s vneshnesekretornoy nedostatochnostyu podzheludochnoy zhelezy [Bioimpedansometry in patients with chronic pancreatitis with exocrine pancreatic insufficiency]. Eksperymentalnaya i klinicheskaya gastroenterologiya – Experimental and Clinical Gastroenterology, 5 (105), 50 [in Russian].
Stepanov, Yu.M., Boiko, T.Y., Sorochan, O.V., & Stoikevych, M.V., & Shkaredna, A.S. (2015). Bioimpedansometriia v otsintsi nutrityvnoho statusu khvorykh na khronichni zapalni zakhvoriuvannia kyshechnyka [Bioimpedansometry in assessing the nutritional status of patients with chronic inflammatory bowel disease]. Hastroenterolohiia – Gastroenterology, 2 (56), 59-66 [in Ukrainian].
Hintaran, A.D., Chenault, M.N., Verhaegh, B.P.M., Reijven, P.L.M., Masclee, A.A.M., & Keulemans, Y.C.A. (2018). Improving nutritional status assessment in patients with chronic pancreatitis. Pancreatology, 18 (7), 785-791.
